Markets log gains for 2nd day on buying in Reliance
时间:2024-09-29 01:31:14 阅读(143)
Equity benchmarks ended higher on Friday helped by buying in index major Reliance Industries along with fresh foreign fund inflows. Extending its previous day’s rally, the 30-share BSE benchmark climbed 203.01 points or 0.34 per cent to settle at 59,959.85. During the day, it jumped 376.33 points or 0.62 per cent to 60,133.17.
On similar lines, the broader NSE Nifty advanced 49.85 points or 0.28 per cent to end at 17,786.80 .
Shares of Maruti climbed nearly 5 per cent after the company announced its earnings.
Also Read: Rupee slips 15 paise to settle at 82.48 against US dollar
Maruti Suzuki India on Friday reported an over four-fold increase in consolidated net profit to Rs 2,112.5 crore in the second quarter ended on September 30, 2022, riding on record sales.
Tech Mahindra, Tata Steel, Sun Pharma, ICICI Bank and State Bank of India were among the laggards.
Elsewhere in Asia, markets in Seoul, Tokyo, Shanghai and Hong Kong ended lower.
Stock exchanges in Europe were trading in the negative territory in mid-session deals. Wall Street had ended on a mixed note on Thursday.
International oil benchmark Brent crude was trading 0.84 per cent lower at USD 96.15 per barrel.
Foreign Institutional Investors (FIIs) turned buyers on Thursday as they bought shares worth Rs 2,818.40 crore, as per exchange data.
上一篇:Rating- reduce; Bajaj Fin- New segments to drive growth
下一篇:Woman jumps to death with six-month-old infant from 16th floor in Greater Noida
猜你喜欢
- Refund portal to be not accessible to PACL investors for 5 days due to technical issues- Sebi panel
- What is FogPASS- Indian Railways ensures safety of passengers through this device
- Equity investors richer by over Rs 6
- Reliance, Infosys, ICICI Bank, PB Fintech, Yes Bank, Vodafone Idea, Kotak Bank, GAIL stocks in focus
- Religare Broking’s stock recommendations for a profitable portfolio
- Recap 2023- GST-related key developments that mattered for MSMEs
- What’s dragging Nifty, Sensex down 1% today- Infosys, IT stocks fall; what next for benchmark indices
- Recap 2023- From postpartum depression to Alzheimer’s disease, here are some crucial USFDA approvals this year
- Vishnu Prakash R Punglia IPO subscribed 3